II. Indications
- Severe, refractory COPD with Chronic Bronchitis and frequent exacerbations
III. Mechanism
- PDE3 and PDE4 Inhibitors increase lung, intracellular cAMP
- Bronchodilates and reduces airway inflammation
IV. Medications
- Roflumilast (Daliresp) Tablets
- Ensifentrine (Ohtuvayre) nebulized